Jacky Vonderscher, Enyo Pharma CEO
October 19, 2022 06:05 AM EDT
Financing
Startups
R&D

Scoop: Af­ter hep B set­back, an Or­biMed-backed NASH biotech hunts for part­ners as it rais­es Se­ries C

Kyle LaHucik

Senior Reporter

Al­most four and a half years af­ter un­cloak­ing a €40 mil­lion Se­ries B, a small French biotech hopes to se­cure an­oth­er round of fi­nanc­ing to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times